Nature's Sunshine Products (NATR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jan, 2026Executive summary
Q3 2024 net sales reached $114.6 million, up 3.1% year-over-year (4% in local currency), marking the highest sales volume of the year, led by strong growth in Japan, Taiwan, and Central Europe, but offset by weakness in China and North America.
Net income rose to $4.3 million ($0.23 per diluted share), up from $2.8 million ($0.14–$0.15 per share) last year, reflecting favorable FX gains and lower service fees in China.
Adjusted EBITDA increased 5% to $10.7 million, supported by cost efficiencies and digital platform upgrades.
Growth was driven by digital investments, new product packs in Asia-Pacific, and cost-saving initiatives.
Omnichannel and digital strategies are expected to drive long-term profitable growth and customer retention.
Financial highlights
Gross margin declined to 71.3% from 73.1% due to inflation and FX headwinds.
Operating income was $5.3 million (4.6% of net sales), down from $5.8 million (5.2%).
SG&A expenses were $41.0 million (35.7% of net sales), down from 37.1% last year.
Cash and equivalents stood at $78.7 million with zero debt as of September 30, 2024.
Net cash from operations was $13.1 million, down from $31.6 million last year.
Outlook and guidance
Full-year 2024 net sales guidance raised to $443–$448 million (from $436–$445 million).
Adjusted EBITDA guidance increased to $40–$42 million (from $39–$42 million).
Q4 expected to be flattish, with regional growth moderating from Q3 highs, especially in APAC.
Management expects continued inflationary pressures and FX volatility to impact costs and sales.
Launch of a new digital sales platform in Q4 2024 may temporarily impact customer acquisition.
Latest events from Nature's Sunshine Products
- Record sales and EBITDA growth in 2025 driven by digital and global expansion.NATR
Q4 202510 Mar 2026 - Digital-first growth, premium products, and omni-channel reach drive strong financial outlook.NATR
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 2024 sales and earnings declined, but cash and digital investments remain strong.NATR
Q2 20242 Feb 2026 - Q3 2025 saw record sales, margin expansion, and raised outlook on digital and Asia-Pacific strength.NATR
Q3 202529 Jan 2026 - Digital-first strategy and premium products drive growth and strong financial performance.NATR
2024 Annual Gateway Conference22 Jan 2026 - Premium supplement brand drives global growth with digital, innovation, and margin expansion plans.NATR
2024 Southwest IDEAS Conference12 Jan 2026 - Q4 net sales up 8.5% to $118.2M; 2025 outlook cautious with $445–$470M sales guidance.NATR
Q4 202427 Dec 2025 - 2,854,607 shares registered for resale; no proceeds to issuer; global direct selling focus.NATR
Registration Filing16 Dec 2025 - 2025 Annual Meeting covers director elections, say-on-pay, and auditor ratification, with strong governance.NATR
Proxy Filing2 Dec 2025